Assays, Kits, & Reagents
These antibodies will support the development of assays for therapeutic drug monitoring of tumor necrosis factor alpha inhibitors
| 2 min read
A variety of SARS-CoV-2 (COVID-19) diagnostic tests now exist, and a LIMS can help manage testing, reports, and patient information
| 5+ min read
As demand surges, Hardy Diagnostics has exponentially increased manufacturing production in order to supply customers with critical laboratory products during the COVID-19 pandemic
| 2 min read
Strategic partnership with Autobio Diagnostics Co., Ltd enables Hardy Diagnostics to become exclusive US supplier of a new rapid, one-step lateral flow assay that detects IgM and IgG antibodies to the SARS-CoV-2 virus
| 2 min read
Sample-to-answer method will enable rapid testing in distributed locations
| 2 min read
OncoSpan range expanded to include FFPE and cfDNA formats to mimic solid tumors and liquid biopsy samples, respectively
| 1 min read
New system offers new possibilities for live-cell analysis experiments
| 2 min read
Laboratory ramps up to full capacity of more than 10,000 tests per day with a 24-hour turnaround time
| 2 min read
Bio-Rad's blood-based immunoassay test can help clinicians identify if an individual has developed antibodies against SARS-CoV-2, the virus associated with COVID-19
| 1 min read
Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership
| 2 min read
Bio-Rad offers a portfolio of recombinant, monoclonal anti-idiotypic antibodies and drug-target complex binders for the development of highly selective and sensitive assays
| 2 min read
